{"entity":{"type":"insider","cik":"0001796536","url":"/insider/0001796536","json_url":"/insider/0001796536.json","name":"Sanders Corazon (Corsee) D.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":10,"first":"2023-06-09","last":"2026-06-15","span_basis":"filed_date"},"name_variants":[{"name":"Sanders Corazon (Corsee) D.","source":"filing","n_filings":10,"first_seen":"2023-06-09","last_seen":"2026-06-15"}],"transactions":[{"id":6176492,"accession":"0001796536-26-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001796536-26-000007","line_url":"/filing/0001796536-26-000007#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001796536","owner_name":"Sanders Corazon (Corsee) D.","owner_url":"/insider/0001796536","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":25.05,"price_display":"25.05","price_state":"stated","total_value":50100.0,"total_display":"50,100.00","shares_owned_after":21095.0,"shares_owned_after_display":"21,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-15","scope":"insider"},{"id":6005141,"accession":"0001796536-26-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001796536-26-000005","line_url":"/filing/0001796536-26-000005#line-1","is_derivative":false,"issuer_cik":"0001651308","issuer_name":"BeOne Medicines Ltd.","issuer_ticker":"ONC","issuer_name_source":null,"issuer_url":"/issuer/0001651308","owner_cik":"0001796536","owner_name":"Sanders Corazon (Corsee) D.","owner_url":"/insider/0001796536","role":"Director","officer_title":null,"security_title":"American Depositary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":212.0,"shares_display":"212","price_per_share":309.5896,"price_display":"309.59","price_state":"stated","total_value":65632.9952,"total_display":"65,633.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-22","filed_date":"2026-05-27","scope":"insider"},{"id":5007321,"accession":"0001796536-25-000005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001796536-25-000005","line_url":"/filing/0001796536-25-000005#line-3","is_derivative":false,"issuer_cik":"0001651308","issuer_name":"BeOne Medicines Ltd.","issuer_ticker":"ONC","issuer_name_source":null,"issuer_url":"/issuer/0001651308","owner_cik":"0001796536","owner_name":"Sanders Corazon (Corsee) D.","owner_url":"/insider/0001796536","role":"Director","officer_title":null,"security_title":"American Depositary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1823.0,"shares_display":"1,823","price_per_share":340.2004,"price_display":"340.20","price_state":"stated","total_value":620185.3292,"total_display":"620,185.33","shares_owned_after":804.0,"shares_owned_after_display":"804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-26","filed_date":"2025-12-01","scope":"insider"},{"id":5007317,"accession":"0001796536-25-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001796536-25-000005","line_url":"/filing/0001796536-25-000005#line-2","is_derivative":false,"issuer_cik":"0001651308","issuer_name":"BeOne Medicines Ltd.","issuer_ticker":"ONC","issuer_name_source":null,"issuer_url":"/issuer/0001651308","owner_cik":"0001796536","owner_name":"Sanders Corazon (Corsee) D.","owner_url":"/insider/0001796536","role":"Director","officer_title":null,"security_title":"American Depositary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":804.0,"shares_display":"804","price_per_share":342.474,"price_display":"342.47","price_state":"stated","total_value":275349.096,"total_display":"275,349.10","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-26","filed_date":"2025-12-01","scope":"insider"},{"id":4890061,"accession":"0001651308-25-000139","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001651308-25-000139","line_url":"/filing/0001651308-25-000139#line-2","is_derivative":false,"issuer_cik":"0001651308","issuer_name":"BeOne Medicines Ltd.","issuer_ticker":"ONC","issuer_name_source":null,"issuer_url":"/issuer/0001651308","owner_cik":"0001796536","owner_name":"Sanders Corazon (Corsee) D.","owner_url":"/insider/0001796536","role":"Director","officer_title":null,"security_title":"American Depositary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2665.0,"shares_display":"2,665","price_per_share":337.0,"price_display":"337.00","price_state":"stated","total_value":898105.0,"total_display":"898,105.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-05","filed_date":"2025-09-09","scope":"insider"},{"id":4792671,"accession":"0000950170-25-088878","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-088878","line_url":"/filing/0000950170-25-088878#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001796536","owner_name":"Sanders Corazon (Corsee) D.","owner_url":"/insider/0001796536","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2405.0,"shares_display":"2,405","price_per_share":37.39,"price_display":"37.39","price_state":"stated","total_value":89922.95,"total_display":"89,922.95","shares_owned_after":15344.0,"shares_owned_after_display":"15,344","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-20","filed_date":"2025-06-23","scope":"insider"},{"id":2827072,"accession":"0000950170-24-081302","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-081302","line_url":"/filing/0000950170-24-081302#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001796536","owner_name":"Sanders Corazon (Corsee) D.","owner_url":"/insider/0001796536","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":584.0,"shares_display":"584","price_per_share":40.98,"price_display":"40.98","price_state":"stated","total_value":23932.32,"total_display":"23,932.32","shares_owned_after":12009.0,"shares_owned_after_display":"12,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-02","filed_date":"2024-07-03","scope":"insider"},{"id":2460765,"accession":"0000950170-24-071548","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-071548","line_url":"/filing/0000950170-24-071548#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001796536","owner_name":"Sanders Corazon (Corsee) D.","owner_url":"/insider/0001796536","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1737.0,"shares_display":"1,737","price_per_share":41.1,"price_display":"41.10","price_state":"stated","total_value":71390.7,"total_display":"71,390.70","shares_owned_after":7248.0,"shares_owned_after_display":"7,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-10","filed_date":"2024-06-10","scope":"insider"},{"id":8404318,"accession":"0001209191-23-040269","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-040269","line_url":"/filing/0001209191-23-040269#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001796536","owner_name":"Sanders Corazon (Corsee) D.","owner_url":"/insider/0001796536","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":585.0,"shares_display":"585","price_per_share":46.76,"price_display":"46.76","price_state":"stated","total_value":27354.6,"total_display":"27,354.60","shares_owned_after":8985.0,"shares_owned_after_display":"8,985","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-30","filed_date":"2023-06-30","scope":"insider"},{"id":7910217,"accession":"0001651308-23-000101","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001651308-23-000101","line_url":"/filing/0001651308-23-000101#line-2","is_derivative":false,"issuer_cik":"0001651308","issuer_name":"BeiGene, Ltd.","issuer_ticker":"BGNE","issuer_name_source":null,"issuer_url":"/issuer/0001651308","owner_cik":"0001796536","owner_name":"Sanders Corazon (Corsee) D.","owner_url":"/insider/0001796536","role":"Director","officer_title":null,"security_title":"American Depositary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":478.0,"shares_display":"478","price_per_share":182.6515,"price_display":"182.65","price_state":"stated","total_value":87307.417,"total_display":"87,307.42","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-23","filed_date":"2023-06-27","scope":"insider"},{"id":7910214,"accession":"0001651308-23-000101","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001651308-23-000101","line_url":"/filing/0001651308-23-000101#line-1","is_derivative":false,"issuer_cik":"0001651308","issuer_name":"BeiGene, Ltd.","issuer_ticker":"BGNE","issuer_name_source":null,"issuer_url":"/issuer/0001651308","owner_cik":"0001796536","owner_name":"Sanders Corazon (Corsee) D.","owner_url":"/insider/0001796536","role":"Director","officer_title":null,"security_title":"American Depositary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":180.74,"price_display":"180.74","price_state":"stated","total_value":18074.0,"total_display":"18,074.00","shares_owned_after":478.0,"shares_owned_after_display":"478","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-23","filed_date":"2023-06-27","scope":"insider"},{"id":8333524,"accession":"0001209191-23-035690","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-035690","line_url":"/filing/0001209191-23-035690#line-2","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001796536","owner_name":"Sanders Corazon (Corsee) D.","owner_url":"/insider/0001796536","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1485.0,"shares_display":"1,485","price_per_share":51.65,"price_display":"51.65","price_state":"stated","total_value":76700.25,"total_display":"76,700.25","shares_owned_after":9570.0,"shares_owned_after_display":"9,570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-09","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001515673","name":"Ultragenyx Pharmaceutical Inc.","url":"/issuer/0001515673","role":"Director","n_filings":6,"first_seen":"2023-06-09","last_seen":"2026-06-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001651308","name":"BeOne Medicines Ltd.","url":"/issuer/0001651308","role":"Director","n_filings":4,"first_seen":"2023-06-27","last_seen":"2026-05-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001796536","retrieved_at":"2026-08-21T13:54:55+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}